tiprankstipranks
Trending News
More News >
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126
Hong Kong Market

JW (Cayman) Therapeutics Co. Ltd. (2126) Cash flow

Compare
1 Followers

JW (Cayman) Therapeutics Co. Ltd. Cash Flow

HK:2126's free cash flow for Q2 2025 was ¥-55.14M. For the 2025 fiscal year, HK:2126's free cash flow was decreased by ¥64.13M and operating cash flow was ¥-54.89M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
¥ -333.44M¥ -398.42M¥ -536.72M¥ -561.20M¥ -261.00M
Investing Cash Flow
¥ -15.43M¥ 9.90M¥ -124.08M¥ -137.13M¥ -91.91M
Financing Cash Flow
¥ 90.49M¥ 275.00K¥ 112.35M¥ -30.62M¥ 2.86B
End Cash Position
¥ 757.38M¥ 1.01B¥ 1.38B¥ 1.83B¥ 2.63B
Free Cash Flow
¥ -348.87M¥ -413.00M¥ -613.60M¥ -634.28M¥ -385.24M
Currency in CNY

JW (Cayman) Therapeutics Co. Ltd. Cash Flow